Literature DB >> 12825737

Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination.

F Enquselassie1, W Ayele, A Dejene, T Messele, A Abebe, F T Cutts, D J Nokes.   

Abstract

We undertook a representative survey of measles antibodies in Addis Ababa, Ethiopia 1994, to characterize immunity and transmission. Specific-antibody levels (IU/l) were determined by ELISA for 4654 sera from individuals aged 0-49 years (1805 < 15 years) collected by stratified household-cluster sampling. The proportion seronegative (< 100 IU/l) was 20% (95% CI: 16-25) in children 9-59 months old, declining to 9% (7-12) in 5-9 year olds, 5% (4-7) in 10-14 year olds, and < 1% in adults. The proportion of children (< 15 years old) with low-level antibody (100-255 IU/l) was 8% (7-10). Vaccination and an absence of a history of measles illness were strongly associated with low-level antibody. History of measles vaccination in 9 months to 14-year-old children was approximately 80%. We estimate a primary vaccine failure rate of 21% (12-34) and continued high measles incidence of 22 per 100 susceptibles (19-24) per annum. Our data support the introduction of campaign vaccination in the city in 1998, although higher routine vaccine coverage is required to sustain the impact. The implications of a high prevalence of low-level antibody are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12825737      PMCID: PMC2869989     

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  10 in total

1.  Measles in a tertiary institution in bida, niger state, Nigeria: prevalence, immunization status and mortality pattern.

Authors:  Muhammed Adeboye; Omotayo Adesiyun; Abdulrasheed Adegboye; Edith Eze; Usman Abubakar; Grace Ahmed; Abdullahi Usman; Solomon Amos; Bf Rotimi
Journal:  Oman Med J       Date:  2011-03

2.  A review of data needed to parameterize a dynamic model of measles in developing countries.

Authors:  Emily K Szusz; Louis P Garrison; Chris T Bauch
Journal:  BMC Res Notes       Date:  2010-03-16

3.  Episodic outbreaks bias estimates of age-specific force of infection: a corrected method using measles as an example.

Authors:  M J Ferrari; A Djibo; R F Grais; B T Grenfell; O N Bjørnstad
Journal:  Epidemiol Infect       Date:  2009-06-19       Impact factor: 2.451

4.  Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models.

Authors:  E O Ohuma; E A Okiro; A Bett; J Abwao; S Were; D Samuel; A Vyse; N Gay; D W G Brown; D J Nokes
Journal:  Epidemiol Infect       Date:  2008-06-10       Impact factor: 2.451

5.  Strategies for Coordination of a Serosurvey in Parallel with an Immunization Coverage Survey.

Authors:  Mark A Travassos; Berhane Beyene; Zenaw Adam; James D Campbell; Nigisti Mulholland; Seydou S Diarra; Tassew Kassa; Lisa Oot; Jenny Sequeira; Mardi Reymann; William C Blackwelder; Marcela F Pasetti; Samba O Sow; Robert Steinglass; Amha Kebede; Myron M Levine
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

6.  Gambiense human african trypanosomiasis and immunological memory: effect on phenotypic lymphocyte profiles and humoral immunity.

Authors:  Veerle Lejon; Dieudonné Mumba Ngoyi; Luc Kestens; Luc Boel; Barbara Barbé; Victor Kande Betu; Johan van Griensven; Emmanuel Bottieau; Jean-Jacques Muyembe Tamfum; Jan Jacobs; Philippe Büscher
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

Review 7.  A review of measles control in Kenya, with focus on recent innovations.

Authors:  Kasidet Manakongtreecheep; Robert Davis
Journal:  Pan Afr Med J       Date:  2017-06-21

8.  Assessment of measles immunity among infants in Maputo City, Mozambique.

Authors:  Jagrati V Jani; Carol Holm-Hansen; Tufária Mussá; Arlinda Zango; Ivan Manhiça; Gunnar Bjune; Ilesh V Jani
Journal:  BMC Public Health       Date:  2008-11-12       Impact factor: 3.295

9.  Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination.

Authors:  Amy Wesolowski; Keitly Mensah; Cara E Brook; Miora Andrianjafimasy; Amy Winter; Caroline O Buckee; Richter Razafindratsimandresy; Andrew J Tatem; Jean-Michel Heraud; C Jessica E Metcalf
Journal:  J R Soc Interface       Date:  2016-04       Impact factor: 4.118

10.  Epidemiology of measles in the metropolitan setting, Addis Ababa, Ethiopia, 2005-2014: a retrospective descriptive surveillance data analysis.

Authors:  Munira Nasser Hassen; Abyot Bekele Woyessa; Mekonen Getahun; Berhane Beyene; Lucy Buluanger; Ayesheshem Ademe; Alemayehu Bekele; Adamu Addissie; Amha Kebede; Daddi Jima
Journal:  BMC Infect Dis       Date:  2018-08-14       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.